Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127331841 | 12733184 | 1 | I | 201312 | 20160413 | 20160912 | 20160912 | PER | US-JNJFOC-20160417144 | JANSSEN | 46.82 | YR | A | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127331841 | 12733184 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 127331841 | 12733184 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | TABLET | ||||||||
| 127331841 | 12733184 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 127331841 | 12733184 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | TABLET | ||||||||
| 127331841 | 12733184 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | TABLET | ||||||||
| 127331841 | 12733184 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 202439 | 20 | MG | TABLET | ||||||
| 127331841 | 12733184 | 7 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127331841 | 12733184 | 8 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | 81 | MG | UNSPECIFIED | |||||||
| 127331841 | 12733184 | 9 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 11 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 12 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 13 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 14 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 15 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 16 | C | FISH OIL | FISH OIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 18 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127331841 | 12733184 | 19 | C | RANEXA | RANOLAZINE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127331841 | 12733184 | 1 | Thrombosis prophylaxis |
| 127331841 | 12733184 | 2 | Thrombosis prophylaxis |
| 127331841 | 12733184 | 3 | Cerebrovascular accident prophylaxis |
| 127331841 | 12733184 | 4 | Cerebrovascular accident prophylaxis |
| 127331841 | 12733184 | 5 | Atrial fibrillation |
| 127331841 | 12733184 | 6 | Atrial fibrillation |
| 127331841 | 12733184 | 7 | Product used for unknown indication |
| 127331841 | 12733184 | 8 | Product used for unknown indication |
| 127331841 | 12733184 | 9 | Product used for unknown indication |
| 127331841 | 12733184 | 10 | Product used for unknown indication |
| 127331841 | 12733184 | 11 | Product used for unknown indication |
| 127331841 | 12733184 | 12 | Product used for unknown indication |
| 127331841 | 12733184 | 13 | Product used for unknown indication |
| 127331841 | 12733184 | 14 | Product used for unknown indication |
| 127331841 | 12733184 | 15 | Product used for unknown indication |
| 127331841 | 12733184 | 16 | Product used for unknown indication |
| 127331841 | 12733184 | 17 | Product used for unknown indication |
| 127331841 | 12733184 | 18 | Product used for unknown indication |
| 127331841 | 12733184 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127331841 | 12733184 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127331841 | 12733184 | Coagulopathy | |
| 127331841 | 12733184 | Dysfunctional uterine bleeding |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127331841 | 12733184 | 1 | 20131210 | 20140102 | 0 | |
| 127331841 | 12733184 | 2 | 20130810 | 2013 | 0 | |
| 127331841 | 12733184 | 3 | 20131210 | 20140102 | 0 | |
| 127331841 | 12733184 | 4 | 20130810 | 2013 | 0 | |
| 127331841 | 12733184 | 5 | 20130810 | 2013 | 0 | |
| 127331841 | 12733184 | 6 | 20131210 | 20140102 | 0 | |
| 127331841 | 12733184 | 7 | 1998 | 0 | ||
| 127331841 | 12733184 | 11 | 1997 | 0 | ||
| 127331841 | 12733184 | 13 | 1997 | 0 | ||
| 127331841 | 12733184 | 18 | 1997 | 0 | ||
| 127331841 | 12733184 | 19 | 2005 | 0 |